loadpatents
name:-0.028037071228027
name:-0.024871826171875
name:-0.010125160217285
Wright; Martin C. Patent Filings

Wright; Martin C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wright; Martin C..The latest application filed is for "novel pd-l1 binding polypeptides for imaging".

Company Profile
9.23.23
  • Wright; Martin C. - Belmont MA
  • Wright; Martin C. - Boston MA
  • Wright; Martin C. - Cambridge MA
  • Wright; Martin C. - Biberach an der Riss DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
PET imaging with PD-L1 binding polypeptides
Grant 11,344,639 - Morin , et al. May 31, 2
2022-05-31
Novel Pd-l1 Binding Polypeptides For Imaging
App 20220001040 - MORIN; Paul E. ;   et al.
2022-01-06
PD-L1 binding polypeptides for imaging
Grant 11,173,219 - Morin , et al. November 16, 2
2021-11-16
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
Grant 11,149,077 - Camphausen , et al. October 19, 2
2021-10-19
Libraries of modified fibronectin type III tenth domain-containing polypeptides
Grant 10,995,131 - Chen , et al. May 4, 2
2021-05-04
Bispecific EGFR/IGFIR binding molecules
Grant 10,954,286 - Emanuel , et al. March 23, 2
2021-03-23
Novel Pd-l1 Binding Polypeptides For Imaging
App 20190343972 - Morin; Paul E. ;   et al.
2019-11-14
PD-L1 binding polypeptides for imaging
Grant 10,406,251 - Morin , et al. Sept
2019-09-10
Targeted Therapeutics Based On Engineered Proteins For Tyrosine Kinases Receptors, Including Igf-ir
App 20190202894 - CAMPHAUSEN; Ray ;   et al.
2019-07-04
Pet Imaging With Pd-l1 Binding Polypeptides
App 20190184042 - MORIN; Paul E. ;   et al.
2019-06-20
Bispecific Egfr/igfir Binding Molecules
App 20190153069 - EMANUEL; Stuart ;   et al.
2019-05-23
Methods of treating cancer by administering IGF-IR binding molecules
Grant 10,221,232 - Camphausen , et al.
2019-03-05
Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules
Grant 10,183,987 - Emanuel , et al. Ja
2019-01-22
Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
App 20180162926 - CHEN; Yan ;   et al.
2018-06-14
Bispecific Egfr/igfir Binding Molecules
App 20180037631 - EMANUEL; Stuart ;   et al.
2018-02-08
Inhibitors of type 2 vascular endothelial growth factor receptors
Grant 9,862,758 - Chen , et al. January 9, 2
2018-01-09
Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules
Grant 9,771,411 - Emanuel , et al. September 26, 2
2017-09-26
Novel Pd-l1 Binding Polypeptides For Imaging
App 20170258948 - MORIN; Paul E. ;   et al.
2017-09-14
Targeted Therapeutics Based On Engineered Proteins For Tyrosine Kinases Receptors, Including Igf-ir
App 20170190761 - CAMPHAUSEN; Ray ;   et al.
2017-07-06
Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
App 20160297869 - CHEN; Yan ;   et al.
2016-10-13
Inhibitors of type 2 vascular endothelial growth factor receptors
Grant 9,328,157 - Chen , et al. May 3, 2
2016-05-03
Bispecific Egfr/igfir Binding Molecules
App 20150259398 - EMANUEL; Stuart ;   et al.
2015-09-17
Targeted Therapeutics Based On Engineered Proteins For Tyrosine Kinases Receptors, Including Igf-ir
App 20150252097 - CAMPHAUSEN; Ray ;   et al.
2015-09-10
Bispecific EGFR/IGFIR binding molecules
Grant 9,017,655 - Emanuel , et al. April 28, 2
2015-04-28
Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
App 20140179896 - CHEN; Yan ;   et al.
2014-06-26
Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides
Grant 8,609,613 - Chen , et al. December 17, 2
2013-12-17
Targeted Therapeutics Based On Engineered Proteins For Tyrosine Kinases Receptors, Including Igf-ir
App 20130310317 - CAMPHAUSEN; Ray ;   et al.
2013-11-21
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
Grant 8,470,332 - Camphausen , et al. June 25, 2
2013-06-25
Bispecific Egfr/igfir Binding Molecules
App 20130157948 - EMANUEL; Stuart ;   et al.
2013-06-20
Bispecific EGFR/IGFIR binding molecules
Grant 8,343,501 - Emanuel , et al. January 1, 2
2013-01-01
Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors
Grant 8,324,362 - Chen , et al. December 4, 2
2012-12-04
Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
App 20120283184 - Chen; Yan ;   et al.
2012-11-08
Inhibitors of type 2 vascular endothelial growth factor receptors
Grant 7,858,739 - Chen , et al. December 28, 2
2010-12-28
Inhibitors Of Type 2 Vascular Endothelial Growth Factor Receptors
App 20100310549 - CHEN; YAN ;   et al.
2010-12-09
Pharmacokinetic modulation and compositions for modified FN3 polypeptides
Grant 7,847,062 - Chen , et al. December 7, 2
2010-12-07
Bispecific Egfr/igfir Binding Molecules
App 20100179094 - Emanuel; Stuart ;   et al.
2010-07-15
Targeted Therapeutics Based On Engineered Proteins For Tyrosine Kinases Receptors, Including Igf-ir
App 20100121033 - Camphausen; Ray ;   et al.
2010-05-13
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
App 20080220049 - Chen; Yan ;   et al.
2008-09-11
Pharmacokinetic modulation and compositions for modified Fn3 polypeptides
App 20070160533 - Chen; Yan ;   et al.
2007-07-12
Inhibitors of type 2 vascular endothelial growth factor receptors
App 20070148126 - Chen; Yan ;   et al.
2007-06-28
Methods for generating highly diverse libraries
Grant 6,846,655 - Wagner , et al. January 25, 2
2005-01-25
Methods for producing 5'-nucleic acid-protein conjugates
Grant 6,623,926 - Lohse , et al. September 23, 2
2003-09-23
Polypeptides interactive with Bcl-XL
App 20030032157 - Hammond, Philip W. ;   et al.
2003-02-13
Isolated promoter and terminator of elongation factor 1-.alpha.
Grant 5,650,294 - Kurth , et al. July 22, 1
1997-07-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed